You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Digital Greenhouse

    SBC: Anautics, Inc.            Topic: AF112208

    The Digital Greenhouse concept is to work with users from operational organizations in off-site commercial locations, positioned near Air Force logistics centers, to quickly develop “user storiesâ€Â for use in rapid development of working prototypes. These prototypes will be tested and validated by these users for use in application modernization projects capable of providing advanced ...

    SBIR Phase II 2019 Department of DefenseAir Force
  2. A Novel, Nanostructured, Metal-Organic Frameworks-Based Pretreatment Technology for the Remediation of PFAS in Industrial Wastewater

    SBC: FRAMERGY INC            Topic: 18NCER1C

    Per- and polyflouralkyl substances, otherwise known as PFAS, are a large group of chemicals including perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS). These chemicals have a large variety of uses globally. Remediation of PFAS has gained importance due to their environmental persistence and toxicity. Water treatment methods must combine multiple strategies to be effective, as PF ...

    SBIR Phase I 2019 Environmental Protection Agency
  3. A Novel, Nanostructured, Metal-organic Frameworks-Based Product Loss Prevention Technology in the Oil and Natural Gas Sector

    SBC: FRAMERGY INC            Topic: 18NCERP2

    To reach the end user, oil and gas production at the wellhead must be transmitted through the country and distributed to a wide range of customers. This logisticalsystem requires natural gas gathering lines, processing facilities,product storage tanks and Jots of other equipment. What results is air pollution caused by industry losses during these operations and the use of continuous or intermitte ...

    SBIR Phase II 2019 Environmental Protection Agency
  4. The Mouth Mouse: An Intuitive Bluetooth Controller of Electronic Systems for Persons with Upper-Limb Impairment.

    SBC: KTM LLC            Topic: NA

    This project develops and tests a Bluetooth compliant tongue-based electronic controller (a.k.a. “Mouth Mouse”), designed to give people with upper limb disability control of peripheral devices including computers and communication systems, home automation, and powered wheelchairs, as well as many other Bluetooth compliant devices and new technologies to come in the future. The Mouth Mouse is ...

    SBIR Phase I 2019 Department of Health and Human ServicesAdministration for Community Living
  5. Mobile Health Point-of-Care Diagnostics for Tuberculosis

    SBC: B & W TEK INC            Topic: NIAID

    TuberculosisTBkilled an estimatedmillion people in the world inOverof the mortalities associated with this deisease occurred in regions of the world where access to reliable TB testing and other suppotive infrastructure is severely limitedUntil there are pivotal technological innovations in the diagnosis of TB for point of carePOCapplicationthe ambitious goals of the WHO s End TB strategyareductio ...

    SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  6. DEVELOP NEW COMMERCIALLY VIABLE DEVICES, TOOLS, TECHNOLOGIES OR INTEGRATED SYSTEMS FOR DRUG DETECTION AND DEACTIVATION TO DETER OPIOID THEFT IN HOSPITALS.

    SBC: B & W TEK INC            Topic: NIDA

    The Contractorwill use modern technology to develop a fully integratedcommercially viable device for controlled pharmaceutical drug detectiondeactivationand disposal to ensure compliance with DEA regulations and deter opioid theft

    SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  7. Development of mitoNEET agonists for the treatment of stroke

    SBC: MODULATION THERAPEUTICS, INC.            Topic: 102

    ABSTRACT Stroke is the fifth leading cause of death and the leading cause of disability in the United StatesThere remains a critical need for innovative therapeutic approaches that can successfully prevent or reverse brain injury following strokeDysfunction of the mitochondrial biochemistry following ischemic stroke and reperfusion injury contributes to significant neuronal cell losshoweverthe dev ...

    STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  8. Analytics-Based Platform for Diabetic Retinopathy Care Management

    SBC: RETINAL CARE INC            Topic: NEI

    ABSTRACT Despite the overefficacy of diabetic retinopathyDRtreatmentit continues to be the leading cause of blindness in working age AmericansOvermillion adults in the US have diabetesOf thesewill develop DR andwill develop vision threatening DRVTDRCurrentlyless than half of all patients with diabetes receive the recommended annual dilated eye exam andof those diagnosed with VTDRonlyundergo timely ...

    STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  9. Advancing a Candidate Human Polyclonal Anti-Thymocyte Globulin Product Produced in Transchromosomal Bovine for Transplant Induction/Acute Rejection and T1D Therapy

    SBC: SAB Biotherapeutics, Inc.            Topic: NIAID

    Project Summary Abstract Currently available anti thymocyte globulinATGproducts are polyclonal animal antibodiesATGAMequine polyclonal ATGThymoglobulinrabbit polyclonal ATGand have found broad use as immune tolerizing agentsparticularly for induction therapy in a majority of tissue transplantsfor acute transplant rejectionand as treatment for graft vshost disease following bone marrow transplantsE ...

    SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  10. A Single-Cell Proteomic instrument for Predictive Product Quality Check in Autologous CAR-T Immunotherapies

    SBC: ISOPLEXIS CORPORATION            Topic: 102

    While CAR-T therapies have advanced in the clinic, there are still two specific issues using these breakthrough therapies for blood cancers: Durable responses in patients are only at 30-50% and Cytokine Release Syndrome occurs in 60-90% of treated patients. These limitations, for a drug that costs as much as $500,000, may cost an additional $250,000+ for treating adverse events leading to caution ...

    SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government